New Millennium Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-26
Closed -$247 543
2025
Q2
$247 Hold
26
﹤0.01% 389
2025
Q1
$380 Sell
26
-25
-49% -$384 ﹤0.01% 433
2024
Q4
$763 Buy
51
+12
+31% +$196 ﹤0.01% 473
2024
Q3
$743 Hold
39
﹤0.01% 349
2024
Q2
$798 Buy
+39
New +$775 ﹤0.01% 350
2024
Q1
Sell
-38
Closed -$548 290
2023
Q4
$548 Sell
38
-7
-16% -$95 ﹤0.01% 383
2023
Q3
$774 Buy
45
+4
+10% +$83 ﹤0.01% 342
2023
Q2
$860 Hold
41
﹤0.01% 353
2023
Q1
$966 Hold
41
﹤0.01% 362
2022
Q4
$1.14K Buy
41
+4
+11% +$102 ﹤0.01% 361
2022
Q3
$1K Hold
37
﹤0.01% 338
2022
Q2
$1K Buy
+37
New +$1.3K ﹤0.01% 339

Other funds holding OGN

New Millennium Group's OGN Position: Q3 2025 in Review

New Millennium Group sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 26 shares — an estimated $247 sold.

New Millennium Group first reported a position in OGN in Q2 2022 and held it in 12 quarters. The position peaked at $1.14K in Q4 2022. 669 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • New Millennium Group reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • New Millennium Group sold 26 Organon & Co shares in Q3 2025, an estimated $247.
  • New Millennium Group first reported a position in Organon & Co in Q2 2022 and held it in 12 quarters.
  • New Millennium Group's Organon & Co position peaked at $1.14K in Q4 2022.
  • 669 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on New Millennium Group's 13F filing for Q3 2025, filed 10 Nov 2025.